Table of Contents

company-logo

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.

PDS Biotechnology Dividend Announcement

• PDS Biotechnology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on PDS Biotechnology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

PDS Biotechnology Dividend History

PDS Biotechnology Dividend Yield

PDS Biotechnology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing PDS Biotechnology stock? Use our calculator to estimate your expected dividend yield:

PDS Biotechnology Financial Ratios

P/E ratio-2.93
PEG ratio-6.55
P/B ratio3.86
ROE-137.06%
Payout ratio0.00%
Current ratio3.84
Quick ratio3.84
Cash Ratio3.68

PDS Biotechnology Dividend FAQ

Does PDS Biotechnology stock pay dividends?
PDS Biotechnology does not currently pay dividends to its shareholders.
Has PDS Biotechnology ever paid a dividend?
No, PDS Biotechnology has no a history of paying dividends to its shareholders. PDS Biotechnology is not known for its dividend payments.
Why doesn't PDS Biotechnology pay dividends?
There are several potential reasons why PDS Biotechnology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will PDS Biotechnology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While PDS Biotechnology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is PDS Biotechnology a dividend aristocrat?
PDS Biotechnology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is PDS Biotechnology a dividend king?
PDS Biotechnology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is PDS Biotechnology a dividend stock?
No, PDS Biotechnology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy PDS Biotechnology stocks?
To buy PDS Biotechnology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy PDS Biotechnology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.